The move marks the rise of a new global leader in precision medical manufacturing, combining 75 years of expertise with cutting-edge innovation
BIG LAKE, Minn. — November 4, 2025. Private investment firm SK Capital Partners has officially completed the acquisition of LISI Group’s Medical division, marking the birth of Precera Medical, a newly independent company headquatered in Big Lake, Minnesota. This strategic move positions precera Medical as a leading global CDMO (Contract Development and Manufacturing Organization), serving some of the world’s most advanced medical device manufacturer (OEMs).
The transaction, which closed on October 31, 2025, includes LISI Group’s minority ownership in the new company, reflecting a continued partnership between the two organizations.
From LISI Medical to Precera Medical
With its new name and independent status, Precera Medical Brings over 75 years of engineering and manufacturing excellence to the healthcare industry. The company specialize in producing high precision components and assemblies used in critical medical application such as surgical robotics, minimally invasive surgery, orthopedics and interventional therapies.
Operating from four manufacturing sites—two in the U.S. and two in France, Precera Medical offers full-service solutions that include development, rapid prototyping, precision machining, forging, and automated production.
A Strong Leadership Team to Drive Growth
To lead this next chapter, SK Capital has appointed Dylan Hushka as CEO of Precera Medical. Hushka brings extensive experience from top medical manufacturing firms, including DuPont, Spectrum Plastics Group, and Medtronic. Alongside him, Barry Lederman joins as CFO, having previously served as CFO at Worldwide Clinical Trials and other SK Capital portfolio companies.
“I am proud to join Precera Medical at such an exciting time,” said Hushka. “As a former customer, I’ve always admired the team’s world-class engineering, automation and commitment to quality. We are entering a new era of precision manufacturing defined by speed, reliability and innovation that will help our partners bring breakthrough technologies to patients faster.”
Backed by Expertise and Strategic Vision
To strengthen its leadership, Precera Medical has formed an Advisory Board of respected industry veterans, including Chris Qualters, Art Burghouwt, and Brian Hutchison, alongside representatives from SK Capital and LISI Group.
Josh Lieberman, Principal at SK Capital, shared, “We’re thrilled to support Precera Medical’s next phase of growth. Together, we’ll invest in expanding capacity and capabilities in both organically and through acquisitions to serve the most advanced medical technology companies worldwide.”
Emmanuel Viellard, CEO of LISI Group, added, “This transition represents a proud milestone. The foundation we built since 2010, combined with SK Capital’s resources, sets the stage for Precera Medical to thrive as a world-class, independent company.”
Empowering the Future of Healthcare Innovation
As an independent CDMO, Precera Medical is poised to accelerate innovation across the global medical device market. With a deep focus on precision engineering, automation, and manufacturing excellence, the company aims to become a strategic partner for OEMs driving the next generation of minimally invasive and robotic assisted medical technologies.
The acquisition reflects SK Capital’s continued investment strategy in the specialty materials, ingredients, and life sciences sectors, where it currently manages approximately $10 billion in assets.